Stocks with Implied Volatility Movement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q
October 28, 2016 8:00 AM EDTJefferies reiterated a Hold rating on Bristol-Myers Squibb Co. (NYSE: BMY), and raised the price target to $58.00 (from $54.00), following the company's 3Q. Non-GAAP operating expenses are now expected to be roughly flat through 2020, relative to 2016 levels as part of the company's plan... More
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 12c; Boosts FY16 Outlook; Approves New $3B Stock Buyback Plan
October 27, 2016 7:00 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $0.77, $0.12 better than the analyst estimate of $0.65. Revenue for the quarter came in at $4.83 billion versus the consensus estimate of $4.79 billion.
Bristol-Myers Squibb today announced its Board of Directors approved a new $3 billion repurchase... More
